J.W. Cole Advisors, Inc. Gilead Sciences, Inc. Transaction History

J.W. Cole Advisors, Inc.

$2.42 Billion
Q4 2024

A detailed history of J.W. Cole Advisors, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, J.W. Cole Advisors, Inc. holds 13,597 shares of GILD stock, worth $1.44 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

13,597

Previous 13,462 1.0%

Holding current value

$1.44 Million

Previous $1.13 Million 11.26%

% of portfolio

0.05%

Previous 0.05%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 30, 2025	BUY	$83.95 - $97.9 $11,333 - $13,216	135 Added 1.0%	13,597 $1.26 Million
Q3 2024 Oct 24, 2024	SELL	$66.59 - $83.99 $118,330 - $149,250	-1,777 Reduced 11.66%	13,462 $1.13 Million
Q2 2024 Aug 08, 2024	SELL	$63.15 - $72.88 $1.67 Million - $1.93 Million	-26,497 Reduced 63.49%	15,239 $1.05 Million
Q1 2024 Apr 30, 2024	SELL	$71.58 - $87.29 $10,450 - $12,744	-146 Reduced 0.35%	41,736 $3.06 Million
Q4 2023 Jan 31, 2024	BUY	$73.27 - $83.09 $193,286 - $219,191	2,638 Added 6.72%	41,882 $3.39 Million
Q3 2023 Oct 24, 2023	BUY	$73.94 - $80.67 $294,650 - $321,469	3,985 Added 11.3%	39,244 $2.94 Million
Q2 2023 Jul 27, 2023	BUY	$76.01 - $86.7 $36,028 - $41,095	474 Added 1.36%	35,259 $2.72 Million
Q1 2023 May 03, 2023	BUY	$77.31 - $88.08 $7,035 - $8,015	91 Added 0.26%	34,785 $2.89 Million
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $352,481 - $506,042	-5,656 Reduced 14.02%	34,694 $2.98 Million
Q3 2022 Oct 31, 2022	BUY	$59.54 - $68.01 $88,119 - $100,654	1,480 Added 3.81%	40,350 $2.49 Million
Q2 2022 Jul 27, 2022	BUY	$57.72 - $65.01 $33,131 - $37,315	574 Added 1.5%	38,870 $2.4 Million
Q1 2022 Jun 10, 2022	SELL	$57.92 - $72.58 $24.9 Million - $31.2 Million	-430,301 Reduced 91.83%	38,296 $2.28 Million
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $25.2 Million - $31.6 Million	435,252 Added 1305.3%	468,597 $1.93 Million
Q4 2021 Jan 25, 2022	BUY	$64.88 - $73.64 $135,274 - $153,539	2,085 Added 6.67%	33,345 $2.42 Million
Q3 2021 Oct 26, 2021	BUY	$67.69 - $73.03 $6,295 - $6,791	93 Added 0.3%	31,260 $2.18 Million
Q2 2021 Aug 06, 2021	BUY	$63.47 - $69.35 $55,599 - $60,750	876 Added 2.89%	31,167 $2.15 Million
Q1 2021 Apr 28, 2021	BUY	$60.0 - $68.46 $22,020 - $25,124	367 Added 1.23%	30,291 $1.96 Million
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $226,146 - $257,683	-3,992 Reduced 11.77%	29,924 $1.74 Million
Q3 2020 Nov 05, 2020	BUY	$62.1 - $78.08 $343,971 - $432,485	5,539 Added 19.52%	33,916 $2.14 Million
Q2 2020 Aug 07, 2020	BUY	$72.34 - $84.0 $974,202 - $1.13 Million	13,467 Added 90.32%	28,377 $2.18 Million
Q1 2020 May 07, 2020	SELL	$62.63 - $80.22 $1.1 Million - $1.4 Million	-17,490 Reduced 53.98%	14,910 $1.12 Million
Q4 2019 Jan 23, 2020	BUY	$61.62 - $67.78 $2 Million - $2.2 Million	32,400 New	32,400 $2.11 Million

Others Institutions Holding GILD

# of Institutions

2,045

Shares Held

Call Options Held

10M

Put Options Held

9.05M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $133B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of J.W. Cole Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on J.W. Cole Advisors, Inc. with notifications on news.

Account

J.W. Cole Advisors, Inc. Gilead Sciences, Inc. Transaction History